Citation Impact
Citing Papers
Inflammasome is a central player in the induction of obesity and insulin resistance
2011
Th17 functions as an osteoclastogenic helper T cell subset that links T cell activation and bone destruction
2006
Suppression of bone resorption by madindoline A, a novel nonpeptide antagonist to gp130
2002 StandoutNobel
Preferential recruitment of CCR6-expressing Th17 cells to inflamed joints via CCL20 in rheumatoid arthritis and its animal model
2007 StandoutNobel
Effects of inflammatory and anti‐inflammatory cytokines on the bone
2011
Roles of IFN Consensus Sequence Binding Protein and PU.1 in Regulating IL-18 Gene Expression
1999
Group A Streptococcus Activates Type I Interferon Production and MyD88-dependent Signaling without Involvement of TLR2, TLR4, and TLR9
2008 StandoutNobel
Tumor-derived platelet-derived growth factor-BB plays a critical role in osteosclerotic bone metastasis in an animal model of human breast cancer.
2002
Cytokines and direct cell contact in synovitis: relevance to therapeutic intervention.
1999
Actions of bisphosphonate on bone metastasis in animal models of breast carcinoma
2000
The complexities of skeletal biology
2003 StandoutNature
Cancer Invasion and the Microenvironment: Plasticity and Reciprocity
2011 Standout
Regulation of the differentiation and function of osteoclasts
2000
The Osteoclast Differentiation Factor Osteoprotegerin-Ligand Is Essential for Mammary Gland Development
2000
Interleukin-1β and tumor necrosis factor-α, but not interleukin-6, stimulate osteoprotegerin ligand gene expression in human osteoblastic cells
1999
Intestinal homeostasis and its breakdown in inflammatory bowel disease
2011 StandoutNature
NLRP6 Inflammasome Regulates Colonic Microbial Ecology and Risk for Colitis
2011 Standout
STAT3 Activation in Stromal/Osteoblastic Cells Is Required for Induction of the Receptor Activator of NF-κB Ligand and Stimulation of Osteoclastogenesis by gp130-utilizing Cytokines or Interleukin-1 but Not 1,25-Dihydroxyvitamin D3 or Parathyroid Hormone
1999
Inflammasomes: guardians of cytosolic sanctity
2008
IL-17 in synovial fluids from patients with rheumatoid arthritis is a potent stimulator of osteoclastogenesis
1999
Regulation of Receptor Activator of NF-κB Ligand-induced Osteoclastogenesis by Endogenous Interferon-β (INF-β) and Suppressors of Cytokine Signaling (SOCS)
2002
Inflammasome-mediated dysbiosis regulates progression of NAFLD and obesity
2012 StandoutNature
TRANCE/RANKL Knockout Mice Are Protected from Bone Erosion in a Serum Transfer Model of Arthritis
2001
Recognition of microorganisms and activation of the immune response
2007 StandoutNature
Interleukin-18 induces production of proinflammatory cytokines in mice: no intermediate role for the cytokines of the tumor necrosis factor family and interleukin-1β
2000
Tissue-resident macrophages
2013 Standout
Extending Missing-Self? Functional Interactions Between Lectin-like Nkrp1 Receptors on NK Cells with Lectin-like Ligands
2005
Coordinated cytokine expression by stromal and hematopoietic cells during human osteoclast formation
2000
The Pathogenesis of Rheumatoid Arthritis
2011 Standout
Bone Quality — The Material and Structural Basis of Bone Strength and Fragility
2006 Standout
The bone marrow niche for haematopoietic stem cells
2014 StandoutNature
Expression of osteoclast differentiation factor in rheumatoid arthritis
2000
Evolving concepts of rheumatoid arthritis
2003 StandoutNature
Central roles of NLRs and inflammasomes in viral infection
2010
Docetaxel plus Prednisone or Mitoxantrone plus Prednisone for Advanced Prostate Cancer
2004 Standout
Regulation of osteoclast activity
1999
Altered thymic T-cell selection due to a mutation of the ZAP-70 gene causes autoimmune arthritis in mice
2003 StandoutNatureNobel
TNFα and PTH utilize distinct mechanisms to induce IL-6 and RANKL expression with markedly different kinetics
2005
Interleukin-17 and Type 17 Helper T Cells
2009 Standout
A proinflammatory role for IL-18 in rheumatoid arthritis
1999
Inhibitory action of bisphosphonates on bone resorption does not involve the regulation of RANKL and OPG expression
2002
PU.1 and Interferon Consensus Sequence-binding Protein Regulate the Myeloid Expression of the Human Toll-like Receptor 4 Gene
2000 StandoutNobel
Cytokines, bone remodeling, and estrogen deficiency: a 1998 update
1998
Interleukin-18: a therapeutic target in rheumatoid arthritis?
2005
IL‐1, IL‐18, and IL‐33 families of cytokines
2008
Cell biology of the osteoclast
1999
Endocrine Regulation of Energy Metabolism by the Skeleton
2007 Standout
Mesenchymal and haematopoietic stem cells form a unique bone marrow niche
2010 StandoutNature
Denosumab for Prevention of Fractures in Postmenopausal Women with Osteoporosis
2009 Standout
Osteoclast differentiation and activation
2003 StandoutNature
Estrogen decreases TNF gene expression by blocking JNK activity and the resulting production of c-Jun and JunD
1999
TGFβ in Cancer
2008 Standout
The NLRP3 Inflammasome Protects against Loss of Epithelial Integrity and Mortality during Experimental Colitis
2010
The blockade of immune checkpoints in cancer immunotherapy
2012 Standout
Interleukin‐6 modulates production of T lymphocyte–derived cytokines in antigen‐induced arthritis and drives inflammation‐induced osteoclastogenesis
2005
TNF-α induces osteoclastogenesis by direct stimulation of macrophages exposed to permissive levels of RANK ligand
2000
Sipuleucel-T Immunotherapy for Castration-Resistant Prostate Cancer
2010 Standout
Innate production of TH2 cytokines by adipose tissue-associated c-Kit+Sca-1+ lymphoid cells
2009 StandoutNature
Genetics and pathogenesis of inflammatory bowel disease
2011 StandoutNature
Mechanisms and Functions of Inflammasomes
2014 Standout
Mechanisms of TNF-α– and RANKL-mediated osteoclastogenesis and bone resorption in psoriatic arthritis
2003
Distinct contribution of IL-6, TNF-α, IL-1, and IL-10 to T cell–mediated spontaneous autoimmune arthritis in mice
2004 StandoutNobel
Bone metastasis: the importance of the neighbourhood
2016
Synovial tissue in rheumatoid arthritis is a source of osteoclast differentiation factor
2000
Obesity and the Regulation of Energy Balance
2001 Standout
Mechanisms of Bone Metastasis
2004 Standout
Cytokines in the pathogenesis of rheumatoid arthritis
2007 Standout
Selective Blockade of the Capsaicin Receptor TRPV1 Attenuates Bone Cancer Pain
2005 StandoutNobel
T-cell-mediated regulation of osteoclastogenesis by signalling cross-talk between RANKL and IFN-γ
2000 Nature
The TNF and TNF Receptor Superfamilies
2001 Standout
The potential role of bisphosphonates in prostate cancer
2002
Interleukin-18 Promotes Joint Inflammation and Induces Interleukin-1-Driven Cartilage Destruction
2004
Interleukin-4 Reversibly Inhibits Osteoclastogenesis via Inhibition of NF-κB and Mitogen-activated Protein Kinase Signaling
2002
Transforming Growth Factor-β Stimulates Parathyroid Hormone-related Protein and Osteolytic Metastases via Smad and Mitogen-activated Protein Kinase Signaling Pathways
2002
Granulocyte/Macrophage Colony-Stimulating Factor and Interleukin-3 Correct Osteopetrosis in Mice with Osteopetrosis Mutation
1999
Defective NK Cell Activity and Th1 Response in IL-18–Deficient Mice
1998
Matrix Elasticity Directs Stem Cell Lineage Specification
2006 Standout
Transcriptional Program of Mouse Osteoclast Differentiation Governed by the Macrophage Colony-stimulating Factor and the Ligand for the Receptor Activator of NFκB
2002
A new self: MHC-class-I-independent Natural-killer-cell self-tolerance
2005
Leptin Inhibits Bone Formation through a Hypothalamic Relay
2000 Standout
Hormonal Regulation of Osteoclast Function
1998
Inflammasomes in health and disease
2012 StandoutNature
Tumor-Stromal Interactions in Bone Metastasis
2010
Genetic regulation of osteoclast development and function
2003
Dendritic cells require a systemic type I interferon response to mature and induce CD4+ Th1 immunity with poly IC as adjuvant
2009 StandoutNobel
NK CELL RECOGNITION
2004 Standout
Monitoring Metastatic Behavior of Human Tumor Cells in Mice with Species-Specific Polymerase Chain Reaction: Elevated Expression of Angiogenesis and Bone Resorption Stimulators by Breast Cancer in Bone Metastases
2001
Strontium can increase some osteoblasts without increasing hematopoietic stem cells
2007
Physiology and pathophysiology of bone remodeling.
1999
The Roles of Osteoprotegerin and Osteoprotegerin Ligand in the Paracrine Regulation of Bone Resorption
2000
A Single-Dose Placebo-Controlled Study of AMG 162, a Fully Human Monoclonal Antibody to RANKL, in Postmenopausal Women
2004
Bone Resorption by Osteoclasts
2000 StandoutScience
Lrp6 Hypomorphic Mutation Affects Bone Mass Through Bone Resorption in Mice and Impairs Interaction With Mesd
2008 StandoutNobel
Purification and Characterization of the Human Interleukin-18 Receptor
1997
Osteoclasts and Arthritis
2009
Expression of Interleukin (IL)-18 and Functional IL-18 Receptor on Human Vascular Endothelial Cells, Smooth Muscle Cells, and Macrophages
2002
Mechanisms of TNF-α– and RANKL-mediated osteoclastogenesis and bone resorption in psoriatic arthritis
2003
TNFα Potently Activates Osteoclasts, through a Direct Action Independent of and Strongly Synergistic with RANKL
2002
Paracrine regulation of osteoclast formation and activity: milestones in discovery.
2004
MACROPHAGE RECEPTORS AND IMMUNE RECOGNITION
2005
Synthetic double-stranded RNA induces innate immune responses similar to a live viral vaccine in humans
2011 StandoutNobel
RANK-L and RANK: T Cells, Bone Loss, and Mammalian Evolution
2002
Parathyroid Hormone Stimulates TRANCE and Inhibits Osteoprotegerin Messenger Ribonucleic Acid Expression in Murine Bone Marrow Cultures: Correlation with Osteoclast-Like Cell Formation*
1999
Cytokine Storm
2020 Standout
Birth and Death of Bone Cells: Basic Regulatory Mechanisms and Implications for the Pathogenesis and Treatment of Osteoporosis*
2000 Standout
Catabolic Effects of Continuous Human PTH (1–38) in Vivo Is Associated with Sustained Stimulation of RANKL and Inhibition of Osteoprotegerin and Gene-Associated Bone Formation
2001
Dendritic cell maturation by innate lymphocytes
2005 StandoutNobel
Osteoprotegerin Produced by Osteoblasts Is an Important Regulator in Osteoclast Development and Function*
2000
Macrophage inflammatory protein-1α is an osteoclastogenic factor in myeloma that is independent of receptor activator of nuclear factor κB ligand
2001
A Role for Interleukin-6 in Parathyroid Hormone-Induced Bone Resorption in Vivo1
1999
Distinct contribution of IL-6, TNF-α, IL-1, and IL-10 to T cell–mediated spontaneous autoimmune arthritis in mice
2004 StandoutNobel
Modulation of Osteoclast Differentiation and Function by the New Members of the Tumor Necrosis Factor Receptor and Ligand Families
1999 Standout
Stimulation of Osteoprotegerin Ligand and Inhibition of Osteoprotegerin Production by Glucocorticoids in Human Osteoblastic Lineage Cells: Potential Paracrine Mechanisms of Glucocorticoid-Induced Osteoporosis1
1999
Rational Design of Bisphosphonate Lipid-like Materials for mRNA Delivery to the Bone Microenvironment
2022 StandoutNobel
Commitment and Differentiation of Osteoclast Precursor Cells by the Sequential Expression of C-Fms and Receptor Activator of Nuclear Factor κb (Rank) Receptors
1999
Molecular Biology of Bone Metastasis
2007
A study of the biological receptor activator of nuclear factor-kappaB ligand inhibitor, denosumab, in patients with multiple myeloma or bone metastases from breast cancer.
2006
Altered Immune Responses and Susceptibility to Leishmania major and Staphylococcus aureus Infection in IL-18-Deficient Mice
1999
Antibody to Langerin/CD207 localizes large numbers of CD8α + dendritic cells to the marginal zone of mouse spleen
2009 StandoutNobel
Innate or Adaptive Immunity? The Example of Natural Killer Cells
2011 StandoutScience
Therapeutic Approaches to Bone Diseases
2000 Science
Works of Jan Elliott being referenced
Calcitonin receptor antibodies in the identification of osteoclasts
1999
Osteoclast Inhibitory Lectin, a Family of New Osteoclast Inhibitors
2002
Osteotropic Agents Regulate the Expression of Osteoclast Differentiation Factor and Osteoprotegerin in Osteoblastic Stromal Cells
1998
Interleukin 18 inhibits osteoclast formation via T cell production of granulocyte macrophage colony-stimulating factor.
1998
A Novel Osteoblast-derived C-type Lectin That Inhibits Osteoclast Formation
2001
Isolation of a Human Homolog of Osteoclast Inhibitory Lectin That Inhibits the Formation and Function of Osteoclasts
2004
Breast Cancer Cells Interact with Osteoblasts to Support Osteoclast Formation1
1999
A Combination of Osteoclast Differentiation Factor and Macrophage-Colony Stimulating Factor Is Sufficient for both Human and Mouse Osteoclast Formation in Vitro
1998
Interleukin-18 (Interferon-γ–inducing Factor) Is Produced by Osteoblasts and Acts Via Granulocyte/Macrophage Colony-stimulating Factor and Not Via Interferon-γ to Inhibit Osteoclast Formation
1997
IL-12 Alone and in Synergy with IL-18 Inhibits Osteoclast Formation In Vitro
2001
T-Cells Mediate an Inhibitory Effect of Interleukin-4 on Osteoclastogenesis
2003
Fibroblastic Stromal Cells Express Receptor Activator of NF-κB Ligand and Support Osteoclast Differentiation
2000
A Combination of Osteoclast Differentiation Factor and Macrophage-Colony Stimulating Factor Is Sufficient for both Human and Mouse Osteoclast Formation in Vitro
1998